Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands

被引:45
作者
Zhu, XC
Hart, R
Chang, MS
Kim, JW
Lee, SY
Cao, YA
Mock, D
Ke, E
Saunders, B
Alexander, A
Grossoehme, J
Lin, KM
Yan, Z
Hsueh, R
Lee, J
Scheuermann, RH
Fruman, DA
Seaman, W
Subramaniam, S
Sternweis, P
Simon, MI
Choi, S
机构
[1] CALTECH, Div Biol, Mol Biol Lab, Alliance Cellular Signaling, Pasadena, CA 91125 USA
[2] Univ Calif San Diego, Bioinformat & Data Coordinat Lab, San Diego Supercomp Ctr, Alliance Cellular Signaling, San Diego, CA 92122 USA
[3] Univ Texas, SW Med Ctr, Cell Preparat & Anal Lab, Alliance Cellular Signaling,Dept Pharmacol, Dallas, TX 75390 USA
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[5] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[6] Univ Calif San Francisco, Dept Med, Macrophage Biol Lab, Alliance Cellular Signaling, San Francisco, CA 94143 USA
关键词
D O I
10.4049/jimmunol.173.12.7141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the major patterns of changes in gene expression in mouse splenic B cells in response to stimulation with 33 single ligands for 0.5, 1, 2, and 4 h. We found that ligands known to directly induce or costimulate proliferation, namely, anti-IgM (anti-Ig), anti-CD40 (CD40L), LPS, and, to a lesser extent, IL-4 and CpG-oligodeoxynucleotide (CpG), induced significant expression changes in a large number of genes. The remaining 28 single ligands produced changes in relatively few genes, even though they elicited measurable elevations in intracellular Ca2+ and cAMP concentration and/or protein phosphorylation, including cytokines, chemokines, and other ligands that interact with G protein-coupled receptors. A detailed comparison of gene expression responses to anti-1g, CD40L, LPS, IL-4, and CpG indicates that while many genes had similar temporal patterns of change in expression in response to these ligands, subsets of genes showed unique expression patterns in response to IL-4, anti-1g, and CD40L.
引用
收藏
页码:7141 / 7149
页数:9
相关论文
共 71 条
[1]   THE MARCKS BROTHERS - A FAMILY OF PROTEIN-KINASE-C SUBSTRATES [J].
ADEREM, A .
CELL, 1992, 71 (05) :713-716
[2]  
ALLMAN DM, 1992, J IMMUNOL, V149, P2533
[3]   Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: Importance depends on the nature of the antigen-antibody interaction [J].
Aluvihare, VR ;
Khamlichi, AA ;
Williams, GT ;
Adorini, L ;
Neuberger, MS .
EMBO JOURNAL, 1997, 16 (12) :3553-3562
[4]   An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis [J].
Anderson, JS ;
Teutsch, M ;
Dong, ZJ ;
Wortis, HH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10966-10971
[5]   Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand [J].
Bauer, DE ;
Harris, MH ;
Plas, DR ;
Lum, JJ ;
Hammerman, PS ;
Rathmell, JC ;
Riley, JL ;
Thompson, CB .
FASEB JOURNAL, 2004, 18 (09) :1303-+
[6]   Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B′ subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest [J].
Bennin, DA ;
Don, ASA ;
Brake, T ;
McKenzie, JL ;
Rosenbaum, H ;
Ortiz, L ;
DePaoli-Roach, AA ;
Horne, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :27449-27467
[7]  
BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501
[8]   Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses [J].
Caamaño, JH ;
Rizzo, CA ;
Durham, SK ;
Barton, DS ;
Raventós-Suárez, C ;
Snapper, CM ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :185-196
[9]   IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA [J].
Calfon, M ;
Zeng, HQ ;
Urano, F ;
Till, JH ;
Hubbard, SR ;
Harding, HP ;
Clark, SG ;
Ron, D .
NATURE, 2002, 415 (6867) :92-96
[10]   TRANSITIONAL B-CELLS ARE THE TARGET OF NEGATIVE SELECTION IN THE B-CELL COMPARTMENT [J].
CARSETTI, R ;
KOHLER, G ;
LAMERS, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2129-2140